Why the study?
Does subcutaneous exenatide prevent IR-induced endothelial dysfunction in a human IR injury model?
Population
human ischemia-reperfusion (IR) injury model
Design
Preclinical
Authors
Loading...
Hypothesis-generating for exenatide in IR endothelial protection; human trials needed before clinical consideration.
Does subcutaneous exenatide prevent IR-induced endothelial dysfunction in a human IR injury model?
Exenatide demonstrates protective effects against ischemia-reperfusion-induced endothelial dysfunction via K(ATP) channel activation in a human model.
Ha et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: